Abstract

OBJECTIVESThe usefulness of a novel dopamine transporter PET ligand, [18F]β-CFT in assessing disability in Parkinson's disease was studied.METHODSTwenty seven patients with Parkinson's disease in different disability stages (of which nine...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call